142 related articles for article (PubMed ID: 9657476)
1. Selective ET(A) receptor antagonism reduces neointimal hyperplasia in a porcine coronary stent model.
McKenna CJ; Burke SE; Opgenorth TJ; Padley RJ; Camrud LJ; Camrud AR; Johnson J; Carlson PJ; Lerman A; Holmes DR; Schwartz RS
Circulation; 1998 Jun; 97(25):2551-6. PubMed ID: 9657476
[TBL] [Abstract][Full Text] [Related]
2. Effects of L-749,329, an ET(A)/ET(B) endothelin receptor antagonist, in a porcine coronary artery injury model of vascular restenosis.
Huckle WR; Drag MD; Acker WR; Powers M; McFall RC; Holder DJ; Walsh TF; Schwartz RS; Greenlee WJ; Johnson RG
Circulation; 2001 Apr; 103(14):1899-905. PubMed ID: 11294810
[TBL] [Abstract][Full Text] [Related]
3. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
[TBL] [Abstract][Full Text] [Related]
4. Single-dose intramuscular administration of sustained-release Angiopeptin reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model.
Hong MK; Kent KM; Tio FO; Foegh M; Kornowski R; Bramwell O; Cathapermal SS; Leon MB
Coron Artery Dis; 1997 Feb; 8(2):101-4. PubMed ID: 9211050
[TBL] [Abstract][Full Text] [Related]
5. Saline infusion via local drug delivery catheters is associated with increased neointimal hyperplasia in a porcine coronary in-stent restenosis model.
Kim WH; Hong MK; Kornowski R; Tio FO; Leon MB
Coron Artery Dis; 1999 Dec; 10(8):629-32. PubMed ID: 10599542
[TBL] [Abstract][Full Text] [Related]
6. The effects of uncontrolled hyperglycemia on thrombosis and formation of neointima after coronary stent placement in a novel diabetic porcine model of restenosis.
Carter AJ; Bailey L; Devries J; Hubbard B
Coron Artery Dis; 2000 Sep; 11(6):473-9. PubMed ID: 10966133
[TBL] [Abstract][Full Text] [Related]
7. Selective antagonism of the ET(A) receptor reduces neointimal hyperplasia after balloon-induced vascular injury in pigs.
Burke SE; Lubbers NL; Gagne GD; Wessale JL; Dayton BD; Wegner CD; Opgenorth TJ
J Cardiovasc Pharmacol; 1997 Jul; 30(1):33-41. PubMed ID: 9268219
[TBL] [Abstract][Full Text] [Related]
8. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model.
Carter AJ; Laird JR; Farb A; Kufs W; Wortham DC; Virmani R
J Am Coll Cardiol; 1994 Nov; 24(5):1398-405. PubMed ID: 7930266
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model.
Huang Y; Salu K; Liu X; Li S; Wang L; Verbeken E; Bosmans J; De Scheerder I
Heart; 2004 Feb; 90(2):195-9. PubMed ID: 14729797
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory efficacy of pitavastatin on the early inflammatory response and neointimal thickening in a porcine coronary after stenting.
Yokoyama T; Miyauchi K; Kurata T; Satoh H; Daida H
Atherosclerosis; 2004 Jun; 174(2):253-9. PubMed ID: 15136055
[TBL] [Abstract][Full Text] [Related]
11. Continuous subcutaneous angiopeptin treatment significantly reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model.
Hong MK; Kent KM; Mehran R; Mintz GS; Tio FO; Foegh M; Wong SC; Cathapermal SS; Leon MB
Circulation; 1997 Jan; 95(2):449-54. PubMed ID: 9008463
[TBL] [Abstract][Full Text] [Related]
12. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia.
Kornowski R; Hong MK; Tio FO; Bramwell O; Wu H; Leon MB
J Am Coll Cardiol; 1998 Jan; 31(1):224-30. PubMed ID: 9426044
[TBL] [Abstract][Full Text] [Related]
13. Relationship of vascular thrombosis and inflammatory leukocyte infiltration to neointimal growth following porcine coronary artery stent placement.
Miller DD; Karim MA; Edwards WD; Schwartz RS
Atherosclerosis; 1996 Aug; 124(2):145-55. PubMed ID: 8830928
[TBL] [Abstract][Full Text] [Related]
14. Stents covered by an autologous arterial graft in porcine coronary arteries: feasibility, vascular injury and effect on neointimal hyperplasia.
Stefanadis C; Toutouzas K; Tsiamis E; Vlachopoulos C; Vaina S; Tsekoura D; Haldi L; Stefanadi E; Gravanis M; Toutouzas P
Cardiovasc Res; 1999 Feb; 41(2):433-42. PubMed ID: 10341842
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis.
Heldman AW; Cheng L; Jenkins GM; Heller PF; Kim DW; Ware M; Nater C; Hruban RH; Rezai B; Abella BS; Bunge KE; Kinsella JL; Sollott SJ; Lakatta EG; Brinker JA; Hunter WL; Froehlich JP
Circulation; 2001 May; 103(18):2289-95. PubMed ID: 11342479
[TBL] [Abstract][Full Text] [Related]
16. Fibrin-film stenting in a porcine coronary injury model: efficacy and safety compared with uncoated stents.
McKenna CJ; Camrud AR; Sangiorgi G; Kwon HM; Edwards WD; Holmes DR; Schwartz RS
J Am Coll Cardiol; 1998 May; 31(6):1434-8. PubMed ID: 9581746
[TBL] [Abstract][Full Text] [Related]
17. Coronary artery overexpansion increases neointimal hyperplasia after stent placement in a porcine model.
Russo RJ; Silva PD; Yeager M
Heart; 2007 Dec; 93(12):1609-15. PubMed ID: 17639098
[TBL] [Abstract][Full Text] [Related]
18. A randomized animal study evaluating the efficacies of locally delivered heparin and urokinase for reducing in-stent restenosis.
Kornowski R; Hong MK; Tio FO; Choi SK; Bramwell O; Leon MB
Coron Artery Dis; 1997 May; 8(5):293-8. PubMed ID: 9285182
[TBL] [Abstract][Full Text] [Related]
19. Polymer stent coating for prevention of neointimal hyperplasia.
Billinger M; Buddeberg F; Hubbell JA; Elbert DL; Schaffner T; Mettler D; Windecker S; Meier B; Hess OM
J Invasive Cardiol; 2006 Sep; 18(9):423-6; discussion 427. PubMed ID: 16954581
[TBL] [Abstract][Full Text] [Related]
20. Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine.
Zhang Q; Lu L; Pu L; Zhang R; Shen J; Zhu Z; Hu J; Yang Z; Chen Q; Shen W
Cardiovasc Diabetol; 2007 Jun; 6():16. PubMed ID: 17550588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
